Presenilin-2 polymorphisms and risk of sporadic AD: Evidence from a meta-analysis

Gene

Volumn 503, Issue 2, 2012, Pages 194-199

  Chen, Chunhai ^a   Zhou, Zhou ^a   Li, Maoquan ^a   Qu, Mingyue ^a   Ma, Qinlong ^a   Zhong, Min ^a   Zhang, Yanwen ^a   Yu, Zhengping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Meta analysis; Polymorphisms; Presenilin 2

Indexed keywords

APOLIPOPROTEIN E4; PRESENILIN 2;

ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; DATA BASE; DATA SYNTHESIS; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

ALZHEIMER DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDEL MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PRESENILIN-2;

EID: 84861799509     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.05.005     Document Type: Article

References (37)

1. Bertram L. Alzheimer's disease genetics current status and future perspectives. Int. Rev. Neurobiol. 2009, 84:167-184.
2. Bertram L., Tanzi R.E. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat. Rev. Neurosci. 2008, 9:768-778.
3. Bertram L., Tanzi R.E. Genome-wide association studies in Alzheimer's disease. Hum. Mol. Genet. 2009, 18:R137-R145.
4. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 2007, 39:17-23.
5. Bertram L., Lill C.M., Tanzi R.E. The genetics of Alzheimer disease: back to the future. Neuron 2010, 68:270-281.
6. Brookes A.J., Howell W.M., Woodburn K., Johnstone E.C., Carothers A. Presenilin-I, presenilin-II, and VLDL-R associations in early onset Alzheimer's disease. Lancet 1997, 350:336-337.
7. Brouwers N., Sleegers K., Van Broeckhoven C. Molecular genetics of Alzheimer's disease: an update. Ann. Med. 2008, 40:562-583.
8. Castellani R.J., Rolston R.K., Smith M.A. Alzheimer disease. Dis. Mon. 2010, 56:484-546.
9. Combarros O., et al. Polymorphisms in the presenilin 1 and presenilin 2 genes and risk for sporadic Alzheimer's disease. J. Neurol. Sci. 1999, 171:88-91.
10. Combarros O., Alvarez-Arcaya A., Sanchez-Guerra M., Infante J., Berciano J. Candidate gene association studies in sporadic Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2002, 14:41-54.
11. DerSimonian R., Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp. Clin. Trials 2007, 28:105-114.
12. Di Natale M., et al. Absence of association between Alzheimer disease and the regulatory region polymorphism of the PS2 gene in an Italian population. Neurosci. Lett. 2003, 343:210-212.
13. Ertekin-Taner N. Genetics of Alzheimer disease in the pre- and post-GWAS era. Alzheimers. Res. Ther. 2010, 2:3.
14. Farrer L.A., et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997, 278:1349-1356.
15. Gacia M., et al. Two polymorphisms of presenilin-2 gene (PSEN2) 5' regulatory region are not associated with Alzheimer's disease (AD) in the Polish population. J. Neural Transm. 2008, 115:85-90.
16. Giedraitis V., et al. Genetic analysis of Alzheimer's disease in the Uppsala Longitudinal Study of Adult Men. Dement. Geriatr. Cogn. Disord. 2009, 27:59-68.
17. Goate A., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991, 349:704-706.
18. Howell W.M., Brookes A.J. Evaluation of multiple presenilin 2 SNPs for association with early-onset sporadic Alzheimer disease. Am. J. Med. Genet. 2002, 111:157-163.
19. Kuhlmann I., Minihane A.M., Huebbe P., Nebel A., Rimbach G. Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review. Lipids Health Dis. 2010, 9:8.
20. Lehmann D.J., et al. Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. Am. J. Epidemiol. 2005, 162:305-317.
21. Levy-Lahad E., et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995, 269:973-977.
22. Liu Z., Jia J. The association of the regulatory region of the presenilin-2 gene with Alzheimer's disease in the Northern Han Chinese population. J. Neurol. Sci. 2008, 264:38-42.
23. Ma X., et al. No association between SOD2 Val16Ala polymorphism and breast cancer susceptibility: a meta-analysis based on 9,710 cases and 11,041 controls. Breast Cancer Res. Treat. 2010, 122:509-514.
24. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
25. Prince J.A., et al. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur. J. Hum. Genet. 2001, 9:437-444.
26. Quan W., et al. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study. J. Neurol. Sci. 2006, 240:71-75.
27. Quan W., Bai Y., Maeda K. The association of polymorphism of presenilin 2 gene promoter region in Alzheimer's disease. Nerv. Dis. Ment. Health 2008, 8:170-173.
28. Riazanskaia N., et al. Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD. Mol. Psychiatry 2002, 7:891-898.
29. Richard F., Amouyel P. Genetic susceptibility factors for Alzheimer's disease. Eur. J. Pharmacol. 2001, 412:1-12.
30. Rodriguez-Manotas M., et al. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism. Brain Res. 2007, 1170:119-128.
31. Santos C., Costa J., Santos J., Vaz-Carneiro A., Lunet N. Caffeine intake and dementia: systematic review and meta-analysis. J. Alzheimers Dis. 2010, 20(Suppl. 1):S187-S204.
32. Shepherd C., McCann H., Halliday G.M. Variations in the neuropathology of familial Alzheimer's disease. Acta Neuropathol. 2009, 118:37-52.
33. Sherrington R., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995, 375:754-760.
34. Singleton A.B., Gibson A.M., Atkinson A.L., Daly A., Morris C.M. Presenilin polymorphisms in Alzheimer's disease. Lancet 1997, 350:958-959.
35. Stroup D.F., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
36. Vina J., Lloret A. Why women have more Alzheimer's disease than men: gender and mitochondrial toxicity of amyloid-beta peptide. J. Alzheimers Dis. 2010, 20(Suppl. 2):S527-S533.
37. Xin X.Y., Ding J.Q., Chen S.D. Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis. J. Alzheimers Dis. 2010, 19:1283-1294.